Skip to content

Clinical trials

Phase 2 Parasomnias trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parasomnias Phase: Phase 2 Country / region: United States Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20092
20101
20121
20181
20191
20202
20211
20221
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Withdrawn2
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University4
Duke University2
University of Utah2
Columbia Northwest Pharmaceuticals1
Kaiser Permanente1
Mariana Cherner, PhD1
Neurim Pharmaceuticals Ltd.1
San Francisco Veterans Affairs Medical Center1
State University of New York - Upstate Medical University1
Tonix Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parasomnias17
Anxiety Disorders3
Post-Acute COVID-19 Syndrome3
Stress Disorders, Post-Traumatic3
Alzheimer Disease2
Opioid-Related Disorders2
Sleep Apnea Syndromes2
Sleep Initiation and Maintenance Disorders2
Sleep Wake Disorders2
Agnosia1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.